|
Market Closed -
Nasdaq
01:00:00 14/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 305.23 USD | -0.15% |
|
+1.45% | +23.81% |
| 11-03 | Krystal Biotech Offers Good Prospects Amid Pipeline Delays, RBC Says | MT |
| 11-03 | RBC Lowers Price Target on Krystal Biotech to $375 From $400, Keeps Outperform Rating | MT |
| Market Cap | 9.05B 8.2B 7.58B 6.84B 12.89B 853B 13.35B 91.07B 36.11B 456B 33.94B 33.22B 1,446B | P/E 2026 * |
39.5x | P/E 2027 * | 32.5x |
|---|---|---|---|---|---|
| Enterprise Value | 8.48B 7.69B 7.11B 6.41B 12.09B 800B 12.51B 85.4B 33.86B 427B 31.83B 31.15B 1,356B | EV / Sales 2026 * |
17.1x | EV / Sales 2027 * | 12.7x |
| Free-Float |
89.35% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| KRYS | Delayed | |
CBOE
| KRYS | Real-time | |
|
Boerse Muenchen
| 4KB | Real-time | |
|
Xetra
| 4KB | Delayed | |
|
Deutsche Boerse AG
| 4KB | Delayed | |
|
Börse Stuttgart
| 4KB | Delayed | |
|
Tradegate
| 4KB | Real-time | |
|
Borsa Italiana
| 1KRYS | End-of-day quote |
Last Transcript: Krystal Biotech, Inc.
| 1 day | -0.15% | ||
| 1 week | +1.45% | ||
| Current month | -8.14% | ||
| 1 month | -4.96% | ||
| 3 months | -7.04% | ||
| 6 months | -2.35% | ||
| Current year | +23.81% |
| 1 week | 297.52 |  | 311.05 |
| 1 month | 281.4 | | 338.91 |
| Current year | 235.6 | | 382.54 |
| 1 year | 202.99 | | 382.54 |
| 3 years | 96.73 | | 382.54 |
| 5 years | 38.86 | | 382.54 |
| 10 years | 8.03 | | 382.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Suma M. Krishnan
COO | Chief Operating Officer | 61 | 15/04/2016 |
| Chief Executive Officer | 61 | 15/04/2016 | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 61 | 15/04/2016 | |
Suma M. Krishnan
BRD | Director/Board Member | 61 | 15/04/2016 |
Daniel Janney
BRD | Director/Board Member | 60 | 01/11/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/09/26 | Free | Director | 1,658 | 0.0056% | ||
| 14/09/26 | Free | Director | 1,658 | 0.0056% | ||
| 14/09/26 | Free | Director | 1,658 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.15% | +1.45% | +51.70% | +206.21% | 9.05B | |
| +1.26% | +6.61% | +41.12% | +135.59% | 1,286B | |
| +0.79% | +3.45% | +46.35% | +93.56% | 688B | |
| +0.20% | +1.28% | +27.01% | +112.80% | 521B | |
| -0.44% | +3.69% | +39.60% | +69.51% | 386B | |
| +0.55% | +0.70% | +59.00% | +44.20% | 364B | |
| -0.12% | +0.74% | +26.78% | +58.43% | 302B | |
| +0.37% | +0.37% | +3.62% | +36.44% | 287B | |
| -0.30% | +1.14% | +38.59% | +74.61% | 252B | |
| +0.08% | +0.71% | +34.25% | +124.32% | 208B | |
| Average | +0.22% | +2.01% | +36.80% | +95.57% | 430B | |
| Weighted average by Cap. | +0.54% | +3.25% | +37.66% | +96.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 497M 451M 417M 376M 709M 46.9B 734M 5.01B 1.99B 25.06B 1.87B 1.83B 79.53B | 635M 575M 532M 480M 905M 59.86B 937M 6.39B 2.53B 31.98B 2.38B 2.33B 101B |
| Net income | 238M 216M 200M 180M 339M 22.44B 351M 2.4B 950M 11.99B 893M 874M 38.06B | 304M 276M 255M 230M 434M 28.7B 449M 3.06B 1.22B 15.33B 1.14B 1.12B 48.66B |
| Net Debt | -563M -510M -472M -426M -803M -53.11B -831M -5.67B -2.25B -28.37B -2.11B -2.07B -90.06B | -986M -893M -826M -746M -1.41B -92.96B -1.45B -9.93B -3.94B -49.66B -3.7B -3.62B -158B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $305.23 | -0.15% | 110,285 |
| 12/11/26 | $305.68 | -1.01% | 157,099 |
| 11/11/26 | $308.81 | +0.75% | 174,779 |
| 10/11/26 | $306.50 | +1.14% | 196,377 |
| 09/11/26 | $303.06 | +0.72% | 281,829 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- KRYS Stock
Select your edition
All financial news and data tailored to specific country editions
